EP Patent

EP3470057B1 — Cationic dry powders comprising magnesium salt

Assigned to Pulmatrix Operating Co Inc · Expires 2021-11-03 · 5y expired

What this patent protects

Patent listed against amikacin-sulfate.

Drugs covered by this patent

amikacin-sulfate (AMIKACIN SULFATE)

Patent Metadata

Patent number: EP3470057B1
Jurisdiction: EP
Classification: —
Expires: 2021-11-03
Drug substance claim: No
Drug product claim: No
Assignee: Pulmatrix Operating Co Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.